Myomo (MYO) Profit After Tax (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 20.92% |
| Jun 30, 2025 | -33.68% |
| Mar 31, 2025 | -1,232.30% |
| Dec 31, 2024 | 73.09% |
| Sep 30, 2024 | 13.84% |
| Jun 30, 2024 | 70.76% |
| Mar 31, 2024 | -55.91% |
| Dec 31, 2023 | -21.25% |
| Sep 30, 2023 | -100.07% |
| Jun 30, 2023 | 61.65% |
| Mar 31, 2023 | -22.00% |
| Dec 31, 2022 | 23.40% |
| Sep 30, 2022 | 2.72% |
| Jun 30, 2022 | -3.34% |
| Mar 31, 2022 | -2.99% |
| Dec 31, 2021 | -32.87% |
| Sep 30, 2021 | 21.53% |
| Jun 30, 2021 | 11.47% |
| Mar 31, 2021 | -74.33% |
| Dec 31, 2020 | 38.83% |
| Sep 30, 2020 | 15.53% |
| Jun 30, 2020 | 13.55% |
| Mar 31, 2020 | -37.68% |
| Dec 31, 2019 | 0.95% |
| Sep 30, 2019 | -8.68% |
| Jun 30, 2019 | 1.26% |
| Mar 31, 2019 | 3.49% |
| Dec 31, 2018 | -1.59% |
| Sep 30, 2018 | -0.77% |
| Jun 30, 2018 | -12.12% |
| Mar 31, 2018 | -23.42% |
| Dec 31, 2017 | -50.94% |
| Sep 30, 2017 | 82.95% |
| Jun 30, 2017 | -374.29% |
| Mar 31, 2017 | -28.49% |
| Dec 31, 2016 | -18.96% |
| Sep 30, 2016 | -34.00% |